Cornea

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Mohamed Shafik Shaheen, MD, speaks about what is new in the management of irregular corneas. Sihem Lazreg, MD, PhD, focuses in particular on the need to redefine keratoconus based on the recently discovered multiplicity of pathogenetic and pathophysiological factors.

PARIS — Subgroup characteristics did not affect the clinical outcomes of SMILE Xtra, according to a study presented by Hyung-Jin Koo, MD, of Nunemiso Eye Center, Seoul, at the European Society of Cataract and Refractive Surgeons meeting.

PARIS — François Malecaze, MD, PhD, speaks about the preliminary results of a study on epi-on corneal cross-linking boosted by supplemental oxygen. He is enthusiastic about this new technique, which in his opinion will replace the standard epi-off procedure.

PARIS — Oxygen-enhanced epithelium-on procedures have expanded the indications of corneal cross-linking and have brought important changes in the management of keratoconus, according to Miltos Balidis, MD, PhD. At the European Society of Cataract and Refractive Surgeons meeting, he speaks about the many advantages of this new approach.

Switzerland-based IROC Science’s clinical study business assets have been acquired by the medical device consulting firm Medeuronet, according to a press release.

Glaukos will set the cornerstone of its new corneal health franchise with the acquisition of Avedro, according to a press release announcing the two companies have entered into a definitive merger agreement.

In this video, Clark Chang, OD, a part of the corneal team at Wills Eye Hospital in Philadelphia and director of Global Medical Affairs at Glaukos, discusses recent advancements in neurotrophic keratitis.

In this video, Clark Chang, OD, a part of the corneal team at Wills Eye Hospital in Philadelphia and director of Global Medical Affairs at Glaukos, discusses challenges in screening and diagnosing neurotrophic keratitis.

In this video, Clark Chang, OD, a part of the corneal team at Wills Eye Hospital in Philadelphia and director of Global Medical Affairs at Glaukos, speaks with Healio about treatment options for neurotrophic keratitis currently in the pipeline.

In this video, Clark Chang, OD, a part of the corneal team at Wills Eye Hospital in Philadelphia and director of Global Medical Affairs at Glaukos, discusses collaborative care in the management of neurotrophic keratitis.